| Analysis | Metabolite Name | Measured Value | Units | Treament | Exposure |
|---|---|---|---|---|---|
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 32841714 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 39733656 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 41106436 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 42682384 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 44959368 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 45226332 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 45251308 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 46239408 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 47423076 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 48278332 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 48611732 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 48742024 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 49270512 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 52629320 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 54232140 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 58259208 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 63512368 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 70107608 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 71817680 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 74802712 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 74812224 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 76934784 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 79641456 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 79676880 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 81686184 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 82624008 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 83989296 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 91800944 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 96263368 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 96969392 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 130351032 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 148157392 | Area under curve | Water | Air |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|